Shanthi Kappagoda, MD
Infectious Disease · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 14
- 3 carriers
- Offices
- 3
Offices
3 locations · Stanford Health Care · 3,152 clinicians in this group
Looking this up.
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
14 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Kappagoda’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
14 of 14 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A105647 · Current
Licensed to practise in California · since 2008 · expires 2028-07-31 · University of California, Davis School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$55,080
Medicare paid this office $55,080 for 200 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 84 | $25,438 | $106 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 60 | $8,969 | $149 |
| New patient visit (60+ min) | 36 | $6,525 | $181 |
| Return visit (30+ min) | 38 | $5,534 | $102 |
| Long return visit (40+ min) | 19 | $3,092 | $147 |
See all 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 84 | $25,438 | $106 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 60 | $8,969 | $149 |
| New patient visit (60+ min) | 36 | $6,525 | $181 |
| Return visit (30+ min) | 38 | $5,534 | $102 |
| Long return visit (40+ min) | 19 | $3,092 | $147 |
| New patient visit (45+ min) | 12 | $1,503 | $125 |
Who their Medicare patients are
200 Original Medicare patients in 2024. Average age 70 · Under 65 19% · 85 and older 10% · Women 46% · Also on Medicaid 40% · Health risk score 2.84. At or below the middle of the specialty; the typical infectious disease clinician is at 3.
Conditions among them: High blood pressure 75% · Diabetes 49% · Coronary heart disease 47% · Chronic kidney disease 47% · Heart failure 42% · Atrial fibrillation 37% · Depression 30% · Cancer 21% · COPD 21% · Dementia 20% · Stroke 19%.
The office billed $232,002, Medicare allowed $70,546 and paid $55,080; for 465 services of 22 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 200 | 465 | 70 | 2.84 | $232,002 | $55,080 |
| 2023 | 186 | 384 | 71 | 3.26 | $186,283 | $43,748 |
| 2022 | 222 | 446 | 71 | 2.91 | $212,831 | $48,043 |
| 2021 | 220 | 567 | 71 | 2.79 | $232,487 | $56,298 |
| 2020 | 225 | 585 | 70 | 2.94 | $203,996 | $52,914 |
| 2019 | 304 | 776 | 71 | 2.68 | $142,595 | $65,223 |
| 2018 | 193 | 685 | 68 | 2.79 | $198,989 | $64,232 |
| 2017 | 175 | 561 | 71 | 2.71 | $163,565 | $50,033 |
| 2016 | 192 | 570 | 70 | 2.62 | $193,027 | $57,867 |
| 2015 | 206 | 688 | 68 | 3.26 | $235,961 | $72,896 |
| 2014 | 138 | 444 | 68 | 2.55 | $146,324 | $45,350 |
| 2013 | 93 | 217 | 68 | 2.16 | $78,155 | $22,674 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 78 | $20,302 | $109 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 52 | $8,283 | $159 |
| New patient visit (60+ min) | 28 | $4,570 | $163 |
| Return visit (30+ min) | 32 | $4,435 | $84 |
| Long return visit (40+ min) | 15 | $2,223 | $124 |
| New patient visit (45+ min) | 15 | $1,812 | $121 |
2022: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 89 | $16,323 | $92 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 78 | $14,210 | $180 |
| Return visit (30+ min) | 46 | $6,771 | $81 |
| Long return visit (40+ min) | 15 | $2,711 | $129 |
| New patient visit (45+ min) | 22 | $2,422 | $110 |
| New patient visit (60+ min) | 16 | $2,372 | $148 |
2021: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 73 | $21,765 | $95 |
| Return visit (30+ min) | 98 | $15,983 | $83 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 30 | $5,551 | $185 |
| Long return visit (40+ min) | 28 | $5,146 | $126 |
| New patient visit (60+ min) | 22 | $3,618 | $164 |
| New patient visit (45+ min) | 20 | $2,320 | $116 |
| Short return visit (20+ min) | 13 | $653 | $44 |
2020: 8 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 69 | $21,142 | $95 |
| Return visit (30+ min) | 94 | $13,894 | $66 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 34 | $6,387 | $188 |
| Long return visit (40+ min) | 19 | $2,328 | $97 |
| New patient visit (45+ min) | 20 | $2,273 | $114 |
| New patient visit (60+ min) | 14 | $1,993 | $142 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $745 | $68 |
| Short return visit (20+ min) | 13 | $613 | $47 |
2019: 6 services
| Return visit (30+ min) | 171 | $26,689 | $67 |
| Long return visit (40+ min) | 80 | $11,144 | $88 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 44 | $10,848 | $94 |
| New patient visit (60+ min) | 37 | $5,430 | $147 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 28 | $5,139 | $184 |
| New patient visit (45+ min) | 36 | $3,539 | $98 |
2018: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 75 | $35,108 | $94 |
| Long return visit (40+ min) | 53 | $8,468 | $96 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 43 | $8,186 | $182 |
| Return visit (30+ min) | 56 | $5,096 | $61 |
| New patient visit (45+ min) | 20 | $2,293 | $115 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $1,046 | $65 |
| Short return visit (20+ min) | 11 | $412 | $37 |
2017: 8 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 73 | $22,809 | $93 |
| Return visit (30+ min) | 63 | $7,560 | $65 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 35 | $6,345 | $181 |
| Long return visit (40+ min) | 33 | $4,035 | $96 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 21 | $2,807 | $122 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 22 | $1,814 | $65 |
| New patient visit (45+ min) | 15 | $1,731 | $115 |
| Short return visit (20+ min) | 22 | $1,228 | $44 |
2016: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 85 | $23,323 | $93 |
| Long return visit (40+ min) | 76 | $12,607 | $94 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 61 | $11,356 | $180 |
| Return visit (30+ min) | 39 | $4,064 | $70 |
| New patient visit (60+ min) | 20 | $2,814 | $141 |
| New patient visit (45+ min) | 15 | $1,731 | $115 |
| Short return visit (20+ min) | 12 | $664 | $44 |
2015: 5 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 91 | $27,126 | $93 |
| Long return visit (40+ min) | 98 | $24,206 | $95 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 77 | $14,199 | $180 |
| New patient visit (60+ min) | 34 | $5,001 | $147 |
| Return visit (30+ min) | 12 | $983 | $66 |
2014: 5 services
| Long return visit (40+ min) | 74 | $16,308 | $95 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 57 | $14,904 | $91 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 42 | $8,364 | $178 |
| New patient visit (60+ min) | 17 | $2,429 | $143 |
| Return visit (30+ min) | 24 | $2,029 | $70 |
2013: 4 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 42 | $7,850 | $174 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 36 | $7,601 | $89 |
| Long return visit (40+ min) | 24 | $2,576 | $92 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 18 | $1,800 | $62 |
Medicaid work
$8,488 in 2024
Medicaid paid $8,488 for 182 billed services this clinician did in 2024, up to 14 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 182 | $8,488 |
| 2024 | 182 | 1 | 14 | $8,488 |
| 2023 | 67 | 1 | 21 | $2,950 |
| 2022 | 38 | 1 | 13 | $1,663 |
| 2021 | 132 | 1 | 14 | $6,965 |
| 2020 | 123 | 2 | 18 | $4,867 |
| 2019 | 174 | 2 | 26 | $6,178 |
| 2018 | 86 | 1 | 14 | $2,391 |
See the largest Medicaid services in earlier years
2023
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 67 | $2,950 |
2022
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 38 | $1,663 |
2021
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 132 | $6,965 |
2020
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 110 | $4,381 |
| Return visit (30+ min) | 13 | $485 |
2019
| Return visit (30+ min) | 149 | $5,166 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 25 | $1,012 |
2018
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 86 | $2,391 |
Drugs they prescribed that Part D paid
$98,714
Pharmacies billed $98,714 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 249) in 2024. At or below the middle of the specialty; the typical infectious disease clinician is at 0%.
206 generic and 43 brand-name prescriptions · $98,714 in drug cost · 141 antibiotic prescriptions to 51 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Prezcobix | 13 | $36,480 | $2,806 |
| Tivicay | 13 | $33,460 | $2,574 |
| Fluconazole | 14 | $902 | $64 |
| Doxycycline Hyclate | 15 | $762 | $51 |
| Ciprofloxacin | 13 | $695 | $53 |
See all 7 drugs
| Prezcobix | 13 | $36,480 | $2,806 |
| Tivicay | 13 | $33,460 | $2,574 |
| Fluconazole | 14 | $902 | $64 |
| Doxycycline Hyclate | 15 | $762 | $51 |
| Ciprofloxacin | 13 | $695 | $53 |
| Amoxicillin-Clavulanate Potass | 29 | $322 | $11 |
| Sulfamethoxazole-Trimethoprim | 23 | $250 | $11 |
Year by year
| 2024 | 249 | 68 | 0% (0) | 17% | $98,714 |
| 2023 | 277 | 59 | None | None | $98,843 |
| 2022 | 326 | 70 | None | None | $92,151 |
| 2021 | 400 | 99 | None | 4% | $143,958 |
| 2020 | 466 | 101 | None | None | $197,860 |
| 2019 | 687 | 161 | None | 11% | $296,261 |
| 2018 | 333 | 59 | 0% (0) | 12% | $41,053 |
| 2017 | 321 | 62 | 0% (0) | 17% | $93,358 |
| 2016 | 308 | 73 | 0% (0) | 10% | $59,845 |
| 2015 | 359 | 81 | None | 11% | $50,402 |
| 2014 | 230 | 43 | 0% (0) | None | $42,430 |
| 2013 | 31 | 13 | 0% (0) | None | $2,925 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 9 drugs
| Prezcobix | 11 | $28,454 | $2,587 |
| Tivicay | 11 | $25,317 | $2,302 |
| Doxycycline Hyclate | 33 | $2,916 | $88 |
| Azithromycin | 12 | $2,016 | $168 |
| Amoxicillin-Clavulanate Potass | 32 | $1,520 | $47 |
| Ethambutol | 11 | $1,050 | $95 |
| Ciprofloxacin | 14 | $986 | $70 |
| Sulfamethoxazole-Trimethoprim | 16 | $509 | $32 |
| Nitrofurantoin Mono-Macro | 15 | $293 | $20 |
2022: 11 drugs
| Ertapenem | 16 | $4,759 | $297 |
| Doxycycline Hyclate | 32 | $4,332 | $135 |
| Vancomycin | 25 | $3,630 | $145 |
| Rifampin | 11 | $2,040 | $185 |
| Doxycycline Monohydrate | 15 | $1,530 | $102 |
| Amikacin Sulfate | 11 | $1,124 | $102 |
| Levofloxacin | 16 | $751 | $47 |
| Ciprofloxacin | 22 | $625 | $28 |
| Sulfamethoxazole-Trimethoprim | 13 | $356 | $27 |
| Ondansetron | 14 | $227 | $16 |
| Amoxicillin-Clavulanate Potass | 32 | $224 | $7 |
2021: 9 drugs
| Doxycycline Hyclate | 61 | $7,844 | $129 |
| Fluconazole | 28 | $3,638 | $130 |
| Cefepime | 13 | $1,430 | $110 |
| Cephalexin | 15 | $1,316 | $88 |
| Doxycycline Monohydrate | 16 | $1,192 | $75 |
| Sulfamethoxazole-Trimethoprim | 30 | $811 | $27 |
| Levofloxacin | 20 | $807 | $40 |
| Clindamycin | 11 | $493 | $45 |
| Amoxicillin-Clavulanate Potass | 14 | $310 | $22 |
2020: 16 drugs
| Daptomycin | 13 | $21,852 | $1,681 |
| Ertapenem | 18 | $14,436 | $802 |
| Vancomycin | 22 | $4,512 | $205 |
| Piperacillin-Tazobactam | 11 | $3,956 | $360 |
| Doxycycline Hyclate | 56 | $3,953 | $71 |
| Fluconazole | 19 | $2,642 | $139 |
| Monurol | 11 | $2,543 | $231 |
| Rifampin | 21 | $1,950 | $93 |
| Doxycycline Monohydrate | 17 | $1,189 | $70 |
| Amoxicillin-Clavulanate Potass | 24 | $1,109 | $46 |
| Levofloxacin | 22 | $889 | $40 |
| Clindamycin | 18 | $515 | $29 |
| Cephalexin | 12 | $370 | $31 |
| Amoxicillin | 14 | $305 | $22 |
| Penicillin V | 14 | $213 | $15 |
| Sulfamethoxazole-Trimethoprim | 27 | $166 | $6 |
2019: 15 drugs
| Zerbaxa | 15 | $58,235 | $3,882 |
| Ertapenem | 34 | $27,434 | $807 |
| Doxycycline Hyclate | 121 | $12,256 | $101 |
| Vancomycin | 53 | $11,048 | $208 |
| Cefpodoxime Proxetil | 13 | $3,418 | $263 |
| Sulfamethoxazole-Trimethoprim | 38 | $3,092 | $81 |
| Rifampin | 29 | $2,787 | $96 |
| Amoxicillin-Clavulanate Potass | 35 | $2,190 | $63 |
| Doxycycline Monohydrate | 31 | $1,490 | $48 |
| Cephalexin | 34 | $1,417 | $42 |
| Cefadroxil | 14 | $891 | $64 |
| Penicillin V | 20 | $736 | $37 |
| Ceftriaxone | 15 | $698 | $47 |
| Ciprofloxacin | 20 | $672 | $34 |
| Levofloxacin | 12 | $328 | $27 |
2018: 9 drugs
| Vancomycin | 19 | $3,009 | $158 |
| Doxycycline Hyclate | 28 | $2,340 | $84 |
| Rifampin | 27 | $1,871 | $69 |
| Ethambutol | 19 | $1,458 | $77 |
| Levofloxacin | 12 | $977 | $81 |
| Clindamycin | 14 | $731 | $52 |
| Cephalexin | 26 | $637 | $24 |
| Azithromycin | 17 | $614 | $36 |
| Sulfamethoxazole-Trimethoprim | 26 | $330 | $13 |
2017: 11 drugs
| Daptomycin | 13 | $52,814 | $4,063 |
| Cancidas | 13 | $18,912 | $1,455 |
| Doxycycline Hyclate | 29 | $2,925 | $101 |
| Rifampin | 32 | $2,627 | $82 |
| Vancomycin | 12 | $2,258 | $188 |
| Ethambutol | 21 | $1,736 | $83 |
| Azithromycin | 23 | $737 | $32 |
| Clindamycin | 17 | $453 | $27 |
| Sulfamethoxazole-Trimethoprim | 43 | $388 | $9 |
| Amoxicillin-Clavulanate Potass | 12 | $326 | $27 |
| Cephalexin | 14 | $240 | $17 |
2016: 12 drugs
| Doxycycline Hyclate | 44 | $4,323 | $98 |
| Vancomycin | 26 | $3,587 | $138 |
| Moxifloxacin | 13 | $2,067 | $159 |
| Rifampin | 17 | $984 | $58 |
| Levofloxacin | 14 | $775 | $55 |
| Cefdinir | 12 | $728 | $61 |
| Clindamycin | 15 | $690 | $46 |
| Cephalexin | 15 | $578 | $39 |
| Amoxicillin-Clavulanate Potass | 15 | $541 | $36 |
| Sulfamethoxazole-Trimethoprim | 32 | $326 | $10 |
| Azithromycin | 12 | $260 | $22 |
| Amoxicillin | 15 | $110 | $7 |
2015: 11 drugs
| Doxycycline Hyclate | 47 | $7,253 | $154 |
| Vancomycin | 21 | $6,485 | $309 |
| Piperacillin-Tazobactam | 11 | $4,247 | $386 |
| Rifampin | 33 | $2,145 | $65 |
| Fluconazole | 12 | $1,299 | $108 |
| Levofloxacin | 25 | $1,207 | $48 |
| Amoxicillin-Clavulanate Potass | 15 | $901 | $60 |
| Clindamycin | 18 | $800 | $44 |
| Azithromycin | 19 | $516 | $27 |
| Cephalexin | 14 | $286 | $20 |
| Sulfamethoxazole-Trimethoprim | 14 | $258 | $18 |
2014: 10 drugs
| Doxycycline Hyclate | 32 | $5,756 | $180 |
| Rifampin | 21 | $2,143 | $102 |
| Cefazolin | 12 | $742 | $62 |
| Amox Tr-Potassium Clavulanate | 12 | $479 | $40 |
| Penicillin V | 13 | $358 | $28 |
| Cephalexin | 11 | $241 | $22 |
| Sulfamethoxazole-Trimethoprim | 17 | $229 | $13 |
| Ciprofloxacin | 11 | $204 | $19 |
| Levofloxacin | 14 | $181 | $13 |
| Isoniazid | 13 | $39 | $3 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1720195381
- Licence
- CA A105647California A105647: Current · expires 2028-07-31
- Trained
- University of California, Davis School of Medicine, 2004
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RI0200X (207RI0200X); Internal medicine (207R00000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2006-08-23
- NPI last updated
- 2024-04-25
- NPI record certified
- 2024-04-25
This is when the NPI record was last certified, not a medical board exam.